 | • レポートコード：MRC2-11QY01678 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインフルエンザ治療薬のグローバル市場について調査・分析したレポートです。種類別（ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他）市場規模、用途別（病院、診療所、薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インフルエンザ治療薬の競争状況、市場シェア ・世界のインフルエンザ治療薬市場：種類別市場規模 2015年-2020年（ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他） ・世界のインフルエンザ治療薬市場：種類別市場規模予測 2021年-2026年（ザナミビル、オセルタミビル、ペラミビル、アマンタジン、リマンタジン、イノシン、その他） ・世界のインフルエンザ治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、薬局、その他） ・世界のインフルエンザ治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、薬局、その他） ・北米のインフルエンザ治療薬市場分析：米国、カナダ ・ヨーロッパのインフルエンザ治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインフルエンザ治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインフルエンザ治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインフルエンザ治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Daiichi Sankyo Company、GlaxoSmithKline、Natco Pharma、F. Hoffmann-La Roche、Teva Pharmaceutical、Sandoz International GmbH (Novartis AG)、Sun Pharmaceutical Industries、Mylan ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
Market Analysis and Insights: Global Influenza Medication Market
The global Influenza Medication market size is projected to reach US$ 558.3 million by 2026, from US$ 530.3 million in 2020, at a CAGR of 4.9%% during 2021-2026.
Global Influenza Medication Scope and Market Size
Influenza Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Influenza Medication market is segmented into
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other
Segment by Application, the Influenza Medication market is segmented into
Hospitals
Clinics
Pharmacies
Others
Regional and Country-level Analysis
The Influenza Medication market is analysed and market size information is provided by regions (countries).
The key regions covered in the Influenza Medication market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Influenza Medication Market Share Analysis
Influenza Medication market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Medication business, the date to enter into the Influenza Medication market, Influenza Medication product introduction, recent developments, etc.
The major vendors covered:
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International GmbH (Novartis AG)
Sun Pharmaceutical Industries
Mylan
1 Study Coverage
1.1 Influenza Medication Product Introduction
1.2 Market Segments
1.3 Key Influenza Medication Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Influenza Medication Market Size Growth Rate by Type
1.4.2 Zanamivir
1.4.3 Oseltamivir
1.4.4 Peramivir
1.4.5 Amantadine
1.4.6 Rimantadine
1.4.7 Inosine
1.4.8 Other
1.5 Market by Application
1.5.1 Global Influenza Medication Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Influenza Medication Market Size, Estimates and Forecasts
2.1.1 Global Influenza Medication Revenue 2015-2026
2.1.2 Global Influenza Medication Sales 2015-2026
2.2 Global Influenza Medication, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Influenza Medication Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Influenza Medication Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Influenza Medication Competitor Landscape by Players
3.1 Influenza Medication Sales by Manufacturers
3.1.1 Influenza Medication Sales by Manufacturers (2015-2020)
3.1.2 Influenza Medication Sales Market Share by Manufacturers (2015-2020)
3.2 Influenza Medication Revenue by Manufacturers
3.2.1 Influenza Medication Revenue by Manufacturers (2015-2020)
3.2.2 Influenza Medication Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza Medication Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Influenza Medication Revenue in 2019
3.2.5 Global Influenza Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Influenza Medication Price by Manufacturers
3.4 Influenza Medication Manufacturing Base Distribution, Product Types
3.4.1 Influenza Medication Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Medication Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Medication Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Influenza Medication Market Size by Type (2015-2020)
4.1.1 Global Influenza Medication Sales by Type (2015-2020)
4.1.2 Global Influenza Medication Revenue by Type (2015-2020)
4.1.3 Influenza Medication Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Influenza Medication Market Size Forecast by Type (2021-2026)
4.2.1 Global Influenza Medication Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Medication Revenue Forecast by Type (2021-2026)
4.2.3 Influenza Medication Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Influenza Medication Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Influenza Medication Market Size by Application (2015-2020)
5.1.1 Global Influenza Medication Sales by Application (2015-2020)
5.1.2 Global Influenza Medication Revenue by Application (2015-2020)
5.1.3 Influenza Medication Price by Application (2015-2020)
5.2 Influenza Medication Market Size Forecast by Application (2021-2026)
5.2.1 Global Influenza Medication Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Medication Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Medication Price Forecast by Application (2021-2026)
6 North America
6.1 North America Influenza Medication by Country
6.1.1 North America Influenza Medication Sales by Country
6.1.2 North America Influenza Medication Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Influenza Medication Market Facts & Figures by Type
6.3 North America Influenza Medication Market Facts & Figures by Application
7 Europe
7.1 Europe Influenza Medication by Country
7.1.1 Europe Influenza Medication Sales by Country
7.1.2 Europe Influenza Medication Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza Medication Market Facts & Figures by Type
7.3 Europe Influenza Medication Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Influenza Medication by Region
8.1.1 Asia Pacific Influenza Medication Sales by Region
8.1.2 Asia Pacific Influenza Medication Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Influenza Medication Market Facts & Figures by Type
8.3 Asia Pacific Influenza Medication Market Facts & Figures by Application
9 Latin America
9.1 Latin America Influenza Medication by Country
9.1.1 Latin America Influenza Medication Sales by Country
9.1.2 Latin America Influenza Medication Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Influenza Medication Market Facts & Figures by Type
9.3 Central & South America Influenza Medication Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Influenza Medication by Country
10.1.1 Middle East and Africa Influenza Medication Sales by Country
10.1.2 Middle East and Africa Influenza Medication Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Influenza Medication Market Facts & Figures by Type
10.3 Middle East and Africa Influenza Medication Market Facts & Figures by Application
11 Company Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Corporation Information
11.1.2 Daiichi Sankyo Company Description and Business Overview
11.1.3 Daiichi Sankyo Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Daiichi Sankyo Company Influenza Medication Products Offered
11.1.5 Daiichi Sankyo Company Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Influenza Medication Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Natco Pharma
11.3.1 Natco Pharma Corporation Information
11.3.2 Natco Pharma Description and Business Overview
11.3.3 Natco Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Natco Pharma Influenza Medication Products Offered
11.3.5 Natco Pharma Related Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Description and Business Overview
11.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Influenza Medication Products Offered
11.4.5 F. Hoffmann-La Roche Related Developments
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Corporation Information
11.5.2 Teva Pharmaceutical Description and Business Overview
11.5.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Teva Pharmaceutical Influenza Medication Products Offered
11.5.5 Teva Pharmaceutical Related Developments
11.6 Sandoz International GmbH (Novartis AG)
11.6.1 Sandoz International GmbH (Novartis AG) Corporation Information
11.6.2 Sandoz International GmbH (Novartis AG) Description and Business Overview
11.6.3 Sandoz International GmbH (Novartis AG) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sandoz International GmbH (Novartis AG) Influenza Medication Products Offered
11.6.5 Sandoz International GmbH (Novartis AG) Related Developments
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Corporation Information
11.7.2 Sun Pharmaceutical Industries Description and Business Overview
11.7.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sun Pharmaceutical Industries Influenza Medication Products Offered
11.7.5 Sun Pharmaceutical Industries Related Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Description and Business Overview
11.8.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mylan Influenza Medication Products Offered
11.8.5 Mylan Related Developments
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Corporation Information
11.1.2 Daiichi Sankyo Company Description and Business Overview
11.1.3 Daiichi Sankyo Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Daiichi Sankyo Company Influenza Medication Products Offered
11.1.5 Daiichi Sankyo Company Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Influenza Medication Market Estimates and Projections by Region
12.1.1 Global Influenza Medication Sales Forecast by Regions 2021-2026
12.1.2 Global Influenza Medication Revenue Forecast by Regions 2021-2026
12.2 North America Influenza Medication Market Size Forecast (2021-2026)
12.2.1 North America: Influenza Medication Sales Forecast (2021-2026)
12.2.2 North America: Influenza Medication Revenue Forecast (2021-2026)
12.2.3 North America: Influenza Medication Market Size Forecast by Country (2021-2026)
12.3 Europe Influenza Medication Market Size Forecast (2021-2026)
12.3.1 Europe: Influenza Medication Sales Forecast (2021-2026)
12.3.2 Europe: Influenza Medication Revenue Forecast (2021-2026)
12.3.3 Europe: Influenza Medication Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Influenza Medication Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Influenza Medication Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Influenza Medication Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Influenza Medication Market Size Forecast by Region (2021-2026)
12.5 Latin America Influenza Medication Market Size Forecast (2021-2026)
12.5.1 Latin America: Influenza Medication Sales Forecast (2021-2026)
12.5.2 Latin America: Influenza Medication Revenue Forecast (2021-2026)
12.5.3 Latin America: Influenza Medication Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Influenza Medication Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Influenza Medication Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Influenza Medication Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Influenza Medication Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Influenza Medication Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Medication Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Influenza Medication Market Segments
Table 2. Ranking of Global Top Influenza Medication Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Influenza Medication Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Zanamivir
Table 5. Major Manufacturers of Oseltamivir
Table 6. Major Manufacturers of Peramivir
Table 7. Major Manufacturers of Amantadine
Table 8. Major Manufacturers of Rimantadine
Table 9. Major Manufacturers of Inosine
Table 10. Major Manufacturers of Other
Table 11. Global Influenza Medication Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Influenza Medication Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Influenza Medication Sales by Regions 2015-2020 (K Units)
Table 14. Global Influenza Medication Sales Market Share by Regions (2015-2020)
Table 15. Global Influenza Medication Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Influenza Medication Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Influenza Medication Sales Share by Manufacturers (2015-2020)
Table 18. Global Influenza Medication Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Influenza Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Medication as of 2019)
Table 20. Influenza Medication Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Influenza Medication Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Influenza Medication Price (2015-2020) (USD/Unit)
Table 23. Influenza Medication Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Influenza Medication Product Type
Table 25. Date of International Manufacturers Enter into Influenza Medication Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Influenza Medication Sales by Type (2015-2020) (K Units)
Table 28. Global Influenza Medication Sales Share by Type (2015-2020)
Table 29. Global Influenza Medication Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Influenza Medication Revenue Share by Type (2015-2020)
Table 31. Influenza Medication Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Influenza Medication Sales by Application (2015-2020) (K Units)
Table 33. Global Influenza Medication Sales Share by Application (2015-2020)
Table 34. North America Influenza Medication Sales by Country (2015-2020) (K Units)
Table 35. North America Influenza Medication Sales Market Share by Country (2015-2020)
Table 36. North America Influenza Medication Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Influenza Medication Revenue Market Share by Country (2015-2020)
Table 38. North America Influenza Medication Sales by Type (2015-2020) (K Units)
Table 39. North America Influenza Medication Sales Market Share by Type (2015-2020)
Table 40. North America Influenza Medication Sales by Application (2015-2020) (K Units)
Table 41. North America Influenza Medication Sales Market Share by Application (2015-2020)
Table 42. Europe Influenza Medication Sales by Country (2015-2020) (K Units)
Table 43. Europe Influenza Medication Sales Market Share by Country (2015-2020)
Table 44. Europe Influenza Medication Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Influenza Medication Revenue Market Share by Country (2015-2020)
Table 46. Europe Influenza Medication Sales by Type (2015-2020) (K Units)
Table 47. Europe Influenza Medication Sales Market Share by Type (2015-2020)
Table 48. Europe Influenza Medication Sales by Application (2015-2020) (K Units)
Table 49. Europe Influenza Medication Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Influenza Medication Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Influenza Medication Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Influenza Medication Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Influenza Medication Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Influenza Medication Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Influenza Medication Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Influenza Medication Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Influenza Medication Sales Market Share by Application (2015-2020)
Table 58. Latin America Influenza Medication Sales by Country (2015-2020) (K Units)
Table 59. Latin America Influenza Medication Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Influenza Medication Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Influenza Medication Revenue Market Share by Country (2015-2020)
Table 62. Latin America Influenza Medication Sales by Type (2015-2020) (K Units)
Table 63. Latin America Influenza Medication Sales Market Share by Type (2015-2020)
Table 64. Latin America Influenza Medication Sales by Application (2015-2020) (K Units)
Table 65. Latin America Influenza Medication Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Influenza Medication Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Influenza Medication Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Influenza Medication Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Influenza Medication Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Influenza Medication Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Influenza Medication Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Influenza Medication Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Influenza Medication Sales Market Share by Application (2015-2020)
Table 74. Daiichi Sankyo Company Corporation Information
Table 75. Daiichi Sankyo Company Description and Major Businesses
Table 76. Daiichi Sankyo Company Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Daiichi Sankyo Company Product
Table 78. Daiichi Sankyo Company Recent Development
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Major Businesses
Table 81. GlaxoSmithKline Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Recent Development
Table 84. Natco Pharma Corporation Information
Table 85. Natco Pharma Description and Major Businesses
Table 86. Natco Pharma Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Natco Pharma Product
Table 88. Natco Pharma Recent Development
Table 89. F. Hoffmann-La Roche Corporation Information
Table 90. F. Hoffmann-La Roche Description and Major Businesses
Table 91. F. Hoffmann-La Roche Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. F. Hoffmann-La Roche Product
Table 93. F. Hoffmann-La Roche Recent Development
Table 94. Teva Pharmaceutical Corporation Information
Table 95. Teva Pharmaceutical Description and Major Businesses
Table 96. Teva Pharmaceutical Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Teva Pharmaceutical Product
Table 98. Teva Pharmaceutical Recent Development
Table 99. Sandoz International GmbH (Novartis AG) Corporation Information
Table 100. Sandoz International GmbH (Novartis AG) Description and Major Businesses
Table 101. Sandoz International GmbH (Novartis AG) Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Sandoz International GmbH (Novartis AG) Product
Table 103. Sandoz International GmbH (Novartis AG) Recent Development
Table 104. Sun Pharmaceutical Industries Corporation Information
Table 105. Sun Pharmaceutical Industries Description and Major Businesses
Table 106. Sun Pharmaceutical Industries Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Sun Pharmaceutical Industries Product
Table 108. Sun Pharmaceutical Industries Recent Development
Table 109. Mylan Corporation Information
Table 110. Mylan Description and Major Businesses
Table 111. Mylan Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Mylan Product
Table 113. Mylan Recent Development
Table 114. Global Influenza Medication Sales Forecast by Regions (2021-2026) (K Units)
Table 115. Global Influenza Medication Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Influenza Medication Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Influenza Medication Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Influenza Medication Sales Forecast by Country (2021-2026) (K Units)
Table 119. North America: Influenza Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Influenza Medication Sales Forecast by Country (2021-2026) (K Units)
Table 121. Europe: Influenza Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Influenza Medication Sales Forecast by Region (2021-2026) (K Units)
Table 123. Asia Pacific: Influenza Medication Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Influenza Medication Sales Forecast by Country (2021-2026) (K Units)
Table 125. Latin America: Influenza Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Influenza Medication Sales Forecast by Country (2021-2026) (K Units)
Table 127. Middle East and Africa: Influenza Medication Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Influenza Medication Players
Table 132. Influenza Medication Customers List
Table 133. Influenza Medication Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Medication Product Picture
Figure 2. Global Influenza Medication Sales Market Share by Type in 2020 & 2026
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Amantadine Product Picture
Figure 7. Rimantadine Product Picture
Figure 8. Inosine Product Picture
Figure 9. Other Product Picture
Figure 10. Global Influenza Medication Sales Market Share by Application in 2020 & 2026
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Pharmacies
Figure 14. Others
Figure 15. Influenza Medication Report Years Considered
Figure 16. Global Influenza Medication Market Size 2015-2026 (US$ Million)
Figure 17. Global Influenza Medication Sales 2015-2026 (K Units)
Figure 18. Global Influenza Medication Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Influenza Medication Sales Market Share by Region (2015-2020)
Figure 20. Global Influenza Medication Sales Market Share by Region in 2019
Figure 21. Global Influenza Medication Revenue Market Share by Region (2015-2020)
Figure 22. Global Influenza Medication Revenue Market Share by Region in 2019
Figure 23. Global Influenza Medication Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Influenza Medication Revenue in 2019
Figure 25. Influenza Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Influenza Medication Sales Market Share by Type (2015-2020)
Figure 27. Global Influenza Medication Sales Market Share by Type in 2019
Figure 28. Global Influenza Medication Revenue Market Share by Type (2015-2020)
Figure 29. Global Influenza Medication Revenue Market Share by Type in 2019
Figure 30. Global Influenza Medication Market Share by Price Range (2015-2020)
Figure 31. Global Influenza Medication Sales Market Share by Application (2015-2020)
Figure 32. Global Influenza Medication Sales Market Share by Application in 2019
Figure 33. Global Influenza Medication Revenue Market Share by Application (2015-2020)
Figure 34. Global Influenza Medication Revenue Market Share by Application in 2019
Figure 35. North America Influenza Medication Sales Growth Rate 2015-2020 (K Units)
Figure 36. North America Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Influenza Medication Sales Market Share by Country in 2019
Figure 38. North America Influenza Medication Revenue Market Share by Country in 2019
Figure 39. U.S. Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 40. U.S. Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 42. Canada Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Influenza Medication Market Share by Type in 2019
Figure 44. North America Influenza Medication Market Share by Application in 2019
Figure 45. Europe Influenza Medication Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Influenza Medication Sales Market Share by Country in 2019
Figure 48. Europe Influenza Medication Revenue Market Share by Country in 2019
Figure 49. Germany Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Influenza Medication Market Share by Type in 2019
Figure 60. Europe Influenza Medication Market Share by Application in 2019
Figure 61. Asia Pacific Influenza Medication Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Influenza Medication Sales Market Share by Region in 2019
Figure 64. Asia Pacific Influenza Medication Revenue Market Share by Region in 2019
Figure 65. China Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Influenza Medication Market Share by Type in 2019
Figure 88. Asia Pacific Influenza Medication Market Share by Application in 2019
Figure 89. Latin America Influenza Medication Sales Growth Rate 2015-2020 (K Units)
Figure 90. Latin America Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Influenza Medication Sales Market Share by Country in 2019
Figure 92. Latin America Influenza Medication Revenue Market Share by Country in 2019
Figure 93. Mexico Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 94. Mexico Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 96. Brazil Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 98. Argentina Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Influenza Medication Market Share by Type in 2019
Figure 100. Latin America Influenza Medication Market Share by Application in 2019
Figure 101. Middle East and Africa Influenza Medication Sales Growth Rate 2015-2020 (K Units)
Figure 102. Middle East and Africa Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Influenza Medication Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Influenza Medication Revenue Market Share by Country in 2019
Figure 105. Turkey Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 106. Turkey Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 108. Saudi Arabia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Influenza Medication Sales Growth Rate (2015-2020) (K Units)
Figure 110. U.A.E Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Influenza Medication Market Share by Type in 2019
Figure 112. Middle East and Africa Influenza Medication Market Share by Application in 2019
Figure 113. North America Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. North America Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Europe Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Asia Pacific Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Latin America Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Middle East and Africa Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
インフルエンザ診断の世界市場（～2026年） Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B viru…- インフルエンザワクチン接種の世界市場（～2026年） Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, …
- インフルエンザ薬の世界市場（～2026年） Market Analysis and Insights: Global Influenza Drugs Market The global Influenza Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Influenza Drugs Scope and Market Size Influenza Drugs market is segmented by Type, …
- 犬用インフルエンザワクチンの世界市場（～2026年） Market Analysis and Insights: Global Canine Influenza Vaccine Market The global Canine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Canine Influenza Vaccine Scope and Market Size Canine Influenza V…
- 馬インフルエンザワクチンの世界市場（～2026年） Market Analysis and Insights: Global Equine Influenza Vaccine Market The global Equine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Equine Influenza Vaccine Scope and Market Size Equine Influenza V…